GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $38.3K invested in Galmed Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

66% less capital invested

Capital invested by funds: $113K → $38.3K (-$74.6K)

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$36K
2
+$1.19K
3
+$7
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$7
5
Wells Fargo
Wells Fargo
California
+$7

Top Sellers

1
-$83.1K
2
-$20K
3
-$3.33K
4
TSS
Two Sigma Securities
New York
-$2.84K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$36.1K
2
$1.19K
3
$713
4
$123
5
$96
6
$34
7
$14
8
$7
9
$7
10
–
11
–
12
–